Clinical Trial Update: Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood? [Phase 3]

View source ↗

Summary

Phase 3 trial of fluvoxamine and sertraline in childhood autism has completed, investigating whether SSRI therapy improves behavioral and mood outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Fluvoxamine (fluvoxamine)
• Sertraline (Sertraline)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Autism | Phase 3 | Status: COMPLETED